Should I buy Genpact (G) stock or is it too late?
⭐ The most reliable of them, either direction: Baird — 68% of its targets hit on this sector (322 calls tested). It aims for $38 (+1.3 %), call made on July 8, 2026, maturing on July 8, 2027 (51 d ago).
Firm-by-firm track record on Genpact
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Needham | 45 % | +8.1 % | 20 | $45 +20% |
| Citigroup | 58 % | +6.3 % | 12 | $36 -4% |
| JP Morgan | 33 % | -7.8 % | 9 | $45 +20% |
✅ Reasons to believe
- Pays a dividend (1.9% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on G, Citigroup (58% hit rate, 12 scored calls), only targets $36 (call made on August 7, 2026, maturing on August 7, 2027) (-4%) in its most recent call, and $43 (call made on October 23, 2025, maturing on October 23, 2026) (+15%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 7 ratings, 5 are neutral.
- Limited upside: the median target is only +4% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on G
Median target $39 (+4%) · 7 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Genpact now?
We won't decide for you. The facts: 29% of analysts rate it a buy, median target $39 (+4%), and Citigroup (most reliable on G, 58%) targets $36. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Genpact?
Not according to analysts: the median target ($39) is still +4% above the current price ($38) (most reliable on G: Citigroup, 58%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Genpact still worth investing in?
It depends on the gap between the price ($38) and its estimated value: analysts target $39 on median (+4%), with 29% buys (most reliable on G: Citigroup, 58%). Cross-check with their real reliability on G and the cautions above. Information, not advice.
What's the main risk in buying G?
Even the most reliable firm on G, Citigroup (58% hit rate, 12 scored calls), only targets $36 (call made on August 7, 2026, maturing on August 7, 2027) (-4%) in its most recent call, and $43 (call made on October 23, 2025, maturing on October 23, 2026) (+15%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Genpact profile (consensus, analyst reliability, price target, performance).